Participated · Series E · Jun 2018

Agari offers the Agari Email Trust Platform, a cloud-native suite that prevents ransomware, account takeover, phishing, business email compromise and other identity-deception attacks across inbound and outbound email. Its core AI, Agari Identity Intelligence™, performs 300 million model updates per day using data from trillions of emails and billions of inboxes to detect identity-based attacks. The company also develops domain authentication technology based on the DMARC standard and claims more than a 60% share of protected email sending domains worldwide, including six of the top 10 banks. Agari cites a broad enterprise customer base including Aetna, Informatica, Neustar, Air Canada, the U.S. Postal Service, Facebook, Microsoft and Google. Planned use of new capital includes rapid global expansion across Europe and Asia and strengthening channel and technology partnerships to accelerate growth and market share. The company emphasizes ongoing investment in product, data science, and go-to-market capabilities to deepen its market leadership. Agari provides the cloud-based Agari Email Trust Platform that stops targeted phishing by understanding the legitimate identity of email senders and detecting imposter emails. The platform leverages an incorporated analytics engine that ‘learns’ about email identities based on the relationship of the sender and recipient and a global fingerprint. Customers include large companies in financial services, e-commerce, healthcare, logistics and B2B services. Founded in 2009 and led by CEO Patrick Peterson, the company is based in San Mateo, CA. Agari raised $22m in a Series D and has raised $44.7m in total. It intends to use the new funds to accelerate development and deployment of its platform. Agari provides cloud-based SaaS, data-driven security solutions designed to eliminate email as a channel for cyberattacks and enable safe interactions for businesses and consumers. The company aggregates data from 2.5 billion mailboxes to help global brands eliminate email threats, protect customer personal data, and guard brand reputation. Agari serves large clients across Financial Services, E-Commerce, Healthcare, Logistics and B2B Services. Led by founder and CEO Patrick Peterson, the company intends to use new funds to grow operations. The product focuses on real-time detection and prevention of advanced email attacks for enterprises. Agari is headquartered in San Mateo, California. Agari operates a cloud-based Email Trust Network that collects terabytes of email data to assess, visualize, and protect against email threats such as phishing and fraudulent messages. Its platform processes and protects more than 2.3 billion messages daily and the network covers over two billion mailboxes worldwide, stopping over four million suspicious emails and detecting over 40,000 malicious URLs each day. Agari says it protects more than 65% of US consumer email traffic and counts global leaders in financial services, internet commerce, and social media as customers. The company is a founding member of the DMARC Organization and uses email authentication standards to enable receivers to reject unauthorized messages. In 2012 Agari reported 300% revenue growth and announced a $5 million strategic investment to support expansion. The firm has deep technical roots (founded by leaders behind Cisco’s IronPort) and added senior engineering and CTO hires to accelerate product development and wider adoption. Agari builds an Email Trust Fabric that assesses, visualizes, and protects against email threats to brands, including phishing and other fraud. Its technology, developed by former IronPort/Cisco employees, collects terabytes of data to distinguish legitimate online identities from malicious ones. The company partners with email providers and senders to make sense of the "wild west of email." Agari reports real-time processing of 1.5 billion messages daily and protects major brands in the Financial, E‑Commerce, and Social Media sectors across more than a billion consumer mailboxes. The startup plans to scale its cloud-based Email Trust Fabric to protect brand reputation, eliminate email threats, and prevent loss of sensitive data. Its product was slated for wide release later in November.

Participated · Equity · Jan 2018

AEGEA Medical develops the patented Adaptive Vapor Ablation technology and the AEGEA Vapor System, an FDA‑approved, office‑based endometrial ablation device that uses water vapor to treat menorrhagia. The system is designed to deliver a safe, quick, minimally invasive procedure in a doctor’s office. AEGEA positions the technology as a potential new standard of care for treating heavy menstrual bleeding and to preserve uterine cavity access after ablation. The company plans to commercialize a next‑generation Adaptive Vapor Ablation system in 2019. AEGEA is using recent financing to fund a prospective, multicenter Post‑Ablation Cavity Access (PACE II) study to evaluate uterine cavity access and the feasibility of minimally invasive interventions three to four years post‑ablation. Founded in 2008 and headquartered in Menlo Park, Calif., AEGEA is privately held. AEGEA Medical develops the Adaptive Vapor Ablation system, an FDA‑approved water vapor endometrial ablation technology for treating menorrhagia. The system is designed for office‑based procedures with minimal anesthesia/analgesia and rapid recovery, intended to expand access to appropriate patients. AEGEA is preparing for a commercial U.S. launch of the technology. The company closed a $40 million financing—$30 million led by Perceptive Advisors plus $10 million from existing equity investors—to fund operations during launch preparations. Named existing investors include Alloy Ventures, Delphi Ventures, Medtronic, BioMed Ventures, and Solas BioVentures. AEGEA was founded in 2008 and is based in Redwood City, California. Aegea Medical is a Redwood City, California–based medical device company founded in 2008 and led by CEO Don Gurskis. The company is developing the AEGEA Vapor System, a proprietary convective water vapor technology that delivers controlled, low-pressure natural water vapor to the uterine cavity to ablate the endometrium. The system is designed to deliver adaptive water vapor in an office-based, minutes-long procedure intended to reduce or stop uterine bleeding and improve quality of life for patients with menorrhagia. Aegea closed a $36m Series C financing to support regulatory advancement. The company intends to use the funds to complete its PMA submission and seek FDA approval to market its endometrial ablation procedure. AEGEA Medical is a clinical-stage medical device company developing a novel, minimally invasive global endometrial ablation system that uses vapor to rapidly ablate the uterine lining. The vapor is intended to conform to virtually any anatomy to provide complete ablation, and the procedure is designed to be performed by a gynecologist in an office setting. The company reports positive clinical results to date and plans to complete product development and begin the next stage of clinical testing using the newly raised capital. AEGEA completed a $13.3 million private equity financing led by Covidien Ventures, with Alloy Ventures and Delphi Ventures participating. Amy Belt, Director of Covidien Ventures, has joined AEGEA’s Board of Directors. The company is based in Redwood City, Calif., its products are not yet available for sale in the United States, and it targets a large market—abnormal uterine bleeding affects one in four women of reproductive age with about 2.5 million new U.S. patients seeking treatment annually.

Participated · Series C · Nov 2014

Restoration Robotics is a privately held medical device company based in San Jose, California, dedicated to transforming the field of hair restoration. Its flagship product is the ARTAS System, described as the first and only computer-assisted, physician-controlled system to harvest follicular units directly from the scalp. The company leverages expertise in machine vision, image guidance, visual servoing, robotics, and intuitive interfaces to manage these technologies. Restoration Robotics positions its technology for use by physicians performing hair restoration procedures. The article notes the company is located in the heart of Silicon Valley and emphasizes its focus on advancing hair-restoration robotics. The recent fundraise signals continued investor support for its product and development efforts. Restoration Robotics is a privately held medical device company that develops and commercializes the image-guided ARTAS System, an interactive, computer-assisted robotic arm for harvesting hair follicles using follicular unit extraction (FUE). The ARTAS System combines image-guidance, special imaging technologies, small dissection punches and a computer interface to identify and harvest individual follicular units. The system received FDA 510(k) clearance in April 2011. The company says the technology has potential to transform the global hair restoration market and is preparing for commercialization and a U.S. market launch. Management states the new financing will enable continued innovation, bring the technology to market, and fully support customers.

Participated · Equity · Feb 2014

Gigaom is a media company and blog focused on covering and analyzing emerging technologies. It provides insights on disruptive companies, people and trends and organizes events. The company operates via a network of more than 200 independent analysts. Founded in 2006 by Om Malik, Malik is stepping down as a contributing writer to become a partner with True Ventures. Paul Walborsky is the CEO. The company says it will use the new funds to continue to grow. GigaOm (Giga Omni Media) is a tech blog and research startup. The company operates a research arm that now has more than 20,000 subscribers. Ten of its 41 employees work on research full time, and founder Om Malik says the number of research employees will grow rapidly. GigaOm had previously raised $8.33 million and has just added another $6 million to fund growth. The new capital is intended to fuel expansion of the research business. Sources told TechCrunch the company’s valuation was over $40 million, though GigaOm declined to comment on valuation. Giga Omni Media operates the technology news blog network GigaOm, with its flagship GigaOm blog producing technology journalism and editorial content. The company’s core product is online tech publishing and related editorial services. A TechCrunch report cites an SEC filing showing a fresh $2.5 million raise, bringing total capital raised to $8.33 million. The new capital injection comes from Alloy Ventures and True Ventures (where founder Om Malik is a partner). The company’s most recent prior financing amounted to roughly $4.5 million and closed over two years ago. The report notes recent editorial departures and suggests the company may use funds for growth or acquisitions of smaller blogs. GigaOm is Om Malik’s blog network and one of the early blog networks to raise institutional capital. The company has pursued aggressive expansion and software development according to its leadership. Management said the new funding will also serve as a nest egg for troubled financial times ahead. The company recently promoted Paul Walborsky to CEO. This financing follows prior investment and brings total capital raised to $5.3 million. The round joins other blog networks that have sought outside funding.

Participated · Series B · Jul 2013

Scifiniti has developed SmartWafer, a drop-in photovoltaic (PV) silicon wafer that uses a thin, deposited, high-quality silicon layer on a conductive substrate while matching the form factor of a standard wafer. The company says the SmartWafer enables straightforward replacement in existing processes. Led by CEO Sharone Zehavi, Scifiniti intends to use new capital to bring SmartWafer to market. Financially, the company completed a $10m Series B funding round. Backers in the round included existing investors Alloy Ventures, Firelake Capital, I2BF Global Ventures and Peninsula Ventures. The company is based in San Jose, California.